ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation) |
(I.R.S. Employer Identification No.) |
Title of each class: |
Trading Symbol(s) |
Name of each exchange on which registered: | ||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
Emerging growth company |
Page |
||||||
PART I |
||||||
Item 1. |
3 |
|||||
Item 1A. |
13 |
|||||
Item 1B. |
40 |
|||||
Item 2. |
40 |
|||||
Item 3. |
40 |
|||||
Item 4. |
40 |
|||||
PART II |
||||||
Item 5. |
41 |
|||||
Item 6. |
41 |
|||||
Item 7. |
42 |
|||||
Item 7A. |
51 |
|||||
Item 8. |
51 |
|||||
Item 9. |
51 |
|||||
Item 9A. |
51 |
|||||
Item 9B. |
52 |
|||||
Item 9C. |
52 |
|||||
PART III |
||||||
Item 10. |
53 |
|||||
Item 11. |
56 |
|||||
Item 12. |
64 |
|||||
Item 13. |
67 |
|||||
Item 14. |
70 |
|||||
PART IV |
||||||
Item 15. |
72 |
|||||
Item 16. |
74 |
Item 1. |
Business. |
• | Expand Materials Offering . |
composites and ceramics. We believe that by expanding our materials capabilities and offering a comprehensive and innovative materials portfolio, we will be able to unlock additional opportunities in key markets such as industrial, medical, automotive and aerospace. |
• | Build a Diverse, Global Customer Base . |
• | Expand Within and Beyond Additive Manufacturing . low-volume part production. As our customers scale in volume, they often graduate into these traditional methods; therefore, we believe adding these capabilities will allow us to capture a larger portion of customer spend and grow with our customers’ needs. We plan to leverage our outsourced supply chain partners to support these manufacturing capabilities while we focus our internal manufacturing capabilities on additive manufacturing. |
• | Further Commercialize Software Offering . |
• | Target Strategic M&A and Partnership Opportunities . end-markets, hardware technologies and materials, but many of these manufacturers have not implemented software to fully digitize their manufacturing process and complete their digital transformation. We plan to grow inorganically by acquiring companies that we believe can help us accelerate our investment in new hardware, materials, and finishing capabilities, as well as new geographies and vertical markets. We believe our expertise in both software and manufacturing makes us well positioned to evaluate such opportunities as they become available. |
• | High quality, flexible on-demand manufacturing with proprietary purpose-built softwarelow-volume, complex one-part production at scale. We offer high quality, flexible on-demand manufacturing services to deliver finished end parts to our customers in days instead of the weeks or months that are required by traditional manufacturers. |
• | Platform scalability and quick adaptability to market shifts |
adapt and shift in market changes. We expect to continue adding new hardware providers, manufacturing technologies and materials. We believe that we will benefit from the innovation in hardware and materials across the additive manufacturing market, which will allow us to offer even more materials to our customers. |
• | Enabling platform adoption across customer types and industries |
• | Experienced management team with strong investor support end-to-end |
• | Design in-house experts, we assist with file optimization, file correction, material and technology consultation, and prototyping. We also review digital files so they are optimized for materials, strength, structure, and cost, working closely with our customers to ensure quality and end-user satisfaction. Finally, we offer custom rapid-prototyping services that can accelerate product development by allowing our customers to iterate designs both virtually and physically prior to production. |
• | Production end-parts. We also offer custom-branded packing and fulfillment. Shapeways has high quality, low-volume production with a 30-day average of approximately 98% on-time delivery globally with less than a 1% customer complaint rate for the year ended December 31, 2021. By shipping products directly to our customers’ end customers, we can help reduce the potential for issues related to order fulfillment. The table below shows 10 common materials offered by Shapeways and the 10 types of technologies that are used to manufacture end parts using the material, in each case as of December 2021. |
Name |
Material |
Technology | ||
Accura 60, Accura Xtreme, Accura Xtreme 200, Grey Primed SLA |
Accura 60, Accura Xtreme, Accura Xtreme 200, LT9000 |
SLA | ||
MJF Plastic PA12, PA12GB, Polypropylene |
Nylon 12, Nylon 12 Glass Bead Filled, Polypropylene |
MJF | ||
PA11, TPU, Versatile Plastic, Nylon 6 Mineral Filled , Arnite ® T AM1210 |
Nylon 11, Thermoplastic Polyurethane, Nylon 12, Nylon 6 Mineral Filled, PBT |
SLS |
Name |
Material |
Technology | ||
Multi-Color Polyjet |
Vero |
Polyjet | ||
Stainless Steel 316L, Stainless Steel 17-4PH, 4140 Steel, Copper |
Stainless Steel 316L, Stainless Steel 17-4PH, 4140 Steel, Copper |
BMD | ||
High Definition Full Color, Fine Detail Plastic |
Mimaki MH-100, Visijet M3 Crystal |
Material Jetting | ||
BHDA, Ultracur3D ® RG 35, 5015 Elastomeric Shore A 70, 3843 Tough HDT80, 3172 Tough High Impact |
R5 Gray, Ultracur3D ® RG 35, 5015 Elastomeric Shore A 70, 3843 Tough HDT80, 3172 Tough High Impact |
DLP | ||
EPU 40, RPU 70, UMA 90 |
Elastomeric Polyurethane, Rigid Polyurethane, Urethane Methacrylate |
DLS | ||
Aluminum |
Aluminum |
DMLS | ||
Steel, Stainless Steel 316L |
420 Steel / Bronze (60:40),Stainless Steel 316L, Stainless Steel 17-4PH, Gypsum |
Binder Jetting | ||
Bronze, Brass, Copper, Gold Plated Brass, Gold, Platinum, Rhodium Plated Brass, Silver |
Wax Casting |
Casting |
• | Scale e-commerce providers, allowing our customers who sell consumer-facing goods to connect their stores directly to our platform. Further, our customers have access to our service and support teams, who provide them with deep domain expertise in digital manufacturing technology, materials and production processes. |
• | Improved Accessibility end-to-end |
• | Increased Productivity end-to-end |
• | Expanded Capabilities |
• | Wide range of plastic materials offerings; |
• | Growing portfolio of metals offerings with ability to supply new materials as they become available; |
• | Part quality and consistency across over 23 million parts; |
• | Serving a broad range of customers and industries; |
• | End-to-end |
• | Proprietary software platform to streamline customer operations; |
• | Strategic ecosystem of partner integrations; and |
• | Opportunity to expand to traditional manufacturing capabilities and capture more customers’ share of wallet. |
• | Raise the Bar: For ourselves, our teams, and our products. |
• | Over Communicate: Go above and beyond to keep each other informed. |
• | Win Together: Enable and support each other on the pathway to success. |
• | We have a history of losses and may not achieve or maintain profitability in the future. |
• | We face significant competition and expect to face increasing competition in many aspects of our business, which could cause our operating results to suffer. |
• | The digital manufacturing industry is a relatively new and emerging market and it is uncertain whether it will gain widespread acceptance. |
• | We derive a significant portion of our revenue from business conducted outside the U.S. and are subject to the risk of doing business outside the United States. |
• | If we fail to grow our business as anticipated, our revenues, gross margin, and operating margin will be adversely affected. |
• | If our new and existing solutions and software do not achieve sufficient market acceptance, our financial results and competitive position will decline. |
• | Our attempts to expand our business into new markets and geographies may not be successful. |
• | An active, liquid trading market for our common stock may not develop, which may limit your ability to sell your shares. |
• | Our issuance of additional shares of common stock or convertible securities may dilute your ownership of us and could adversely affect our stock price. |
• | Future sales, or the perception of future sales, of our common stock by us or our existing stockholders in the public market could cause the market price for our common stock to decline. |
• | Our operating results and financial condition may fluctuate on a quarterly and annual basis. |
• | Our stock price may be volatile or may decline regardless of our operating performance. You may lose some or all of your investment. |
• | If securities or industry analysts publish inaccurate or unfavorable research or reports about our business, our stock price and trading volume could decline. |
• | Failure to attract, integrate and retain additional personnel in the future, could harm our business and negatively affect our ability to successfully grow our business. |
• | Interruptions to or other problems with our website user interface, information technology systems, manufacturing processes, or other operations could damage our reputation and brand and substantially harm our business and results of operations. |
• | As part of our growth strategy, we may acquire or make investments in other businesses, patents, technologies, products, or services. We may not realize the anticipated benefits of such investments and integration of these investments may disrupt our business and divert management attention. |
• | The loss of one or more key members of our management team or personnel could harm our business. |
• | We may not timely and effectively scale and adapt our platform, processes, and infrastructure across materials, technologies, markets and software to expand our business. |
• | Our actual results may be significantly different from our projections, estimates, targets, or forecasts. |
• | Develop or obtain leading technologies useful in our business; |
• | Enhance our existing software products; |
• | Develop new services and technologies that address the increasingly sophisticated and varied needs of prospective customers, particularly in the area of materials diversity; |
• | Respond to technological advances and emerging industry standards and practices on a cost-effective and timely basis; |
• | Successfully manage frequent introductions and transitions of technology and software; or |
• | Recruit or retain key technology employees. |
• | misalignment between the solutions and customer needs; |
• | lack of innovation of the solutions; |
• | failure of the solutions to perform in accordance with the customer’s industry standards; |
• | ineffective distribution and marketing; |
• | delay in obtaining any required regulatory approvals; |
• | unexpected production costs; or |
• | release of competitive products. |
• | difficulties in staffing and managing foreign operations; |
• | limited protection for the enforcement of contract and intellectual property rights in certain countries where we may sell our offerings or work with suppliers or other third parties; |
• | potentially longer sales and payment cycles and potentially greater difficulties in collecting accounts receivable; |
• | foreign currency exchange risk; |
• | costs and difficulties of customizing offerings for foreign countries; |
• | challenges in providing solutions across a significant distance, in different languages, and among different cultures; |
• | laws and business practices favoring local competition; |
• | being subject to a wide variety of complex foreign laws, treaties, and regulations and adjusting to any unexpected changes in such laws, treaties, and regulations; |
• | specific and significant regulations, including the European Union’s General Data Protection Regulation, or GDPR, which imposes compliance obligations on companies who possess and use data of EU residents; |
• | uncertainty and resultant political, financial and market instability arising from the United Kingdom’s exit from the European Union; |
• | compliance with U.S. laws affecting activities of U.S. companies abroad, including the U.S. Foreign Corrupt Practices Act; |
• | tariffs, trade barriers, sanctions, and other regulatory or contractual limitations on our ability to sell or develop our offerings in certain foreign markets; |
• | operating in countries with a higher incidence of corruption and fraudulent business practices; |
• | changes in regulatory requirements, including export controls, tariffs and embargoes, other trade restrictions, competition, corporate practices, and data privacy concerns; |
• | supply chain disruptions, which may be exacerbated by the conflict between Russia and Ukraine and the ongoing COVID-19 pandemic; |
• | potential adverse tax consequences arising from global operations; |
• | seasonal reductions in business activity in certain parts of the world, particularly during the summer months in Europe; |
• | rapid changes in government, economic, and political policies and conditions; and |
• | political or civil unrest or instability, regional or larger scale conflicts or geo-political actions, including war or other military conflicts, terrorism or epidemics, and other similar outbreaks or events. |
• | diversion of management’s attention from their day-to-day |
• | unanticipated costs or liabilities associated with the acquisition; |
• | incurrence of acquisition-related costs, which would be recognized as a current period expense; |
• | problems integrating the purchased business, products or technologies; |
• | challenges in achieving strategic objectives, cost savings and other anticipated benefits; |
• | inability to maintain relationships with key customers, suppliers, vendors and other third parties on which the purchased business relies; |
• | the difficulty of incorporating acquired technology and rights into our platform and of maintaining quality and security standards consistent with our brand; |
• | difficulty in maintaining controls, procedures, and policies during the transition and integration; |
• | challenges in integrating the new workforce and the potential loss of key employees, particularly those of the acquired business; and |
• | use of substantial portions of our available cash or the incurrence of debt to consummate the acquisition. |
• | disruptions to or restrictions on our ability to ensure the continuous provision of our manufacturing services and solutions; |
• | temporary closures or reductions in operational capacity of our or third party manufacturing facilities; |
• | reductions in our capacity utilization levels; |
• | temporary closures of our direct and indirect suppliers, resulting in adverse effects to our supply chain, and other supply chain disruptions (which may be exacerbated by war or other military conflict), which adversely affect our ability to procure sufficient inventory to support customer orders; |
• | temporary shortages of skilled employees available to staff manufacturing facilities due to shelter-in- |
• | restrictions or disruptions of transportation, such as reduced availability of air transport, port closures, and increased border controls or closures; |
• | increases in operational expenses and other costs related to requirements implemented to mitigate the impact of the pandemic; |
• | delays or limitations on the ability of our customers to perform or make timely payments; |
• | reductions in short- and long-term demand for our manufacturing services and solutions, or other disruptions in technology buying patterns; |
• | workforce disruptions due to illness, quarantines, governmental actions, other restrictions, and/or the social distancing measures we have taken to mitigate the impact of COVID-19 at our locations around the world in an effort to protect the health and well-being of our employees, customers, suppliers, and of the communities in which we operate (including working from home, restricting the number of employees attending events or meetings in person, limiting the number of people in our buildings and factories at any one time, further restricting access to our facilities and suspending employee travel); and |
• | our management team continuing to commit significant time, attention, and resources to monitoring the COVID-19 pandemic and seeking to mitigate its effects on our business and workforce. |
• | the degree of market acceptance of digital manufacturing and, specifically, our services; |
• | our ability to compete with competitors and new entrants into our markets; |
• | the mix of offerings that we sell during any period; |
• | the timing of our sales and deliveries of our offerings to customers; |
• | the geographic distribution of our sales; |
• | changes in our pricing policies or those of our competitors, including our response to price competition; |
• | changes in the amount that we spend to develop and manufacture new technologies; |
• | changes in the amounts that we spend to promote our services; |
• | expenses and/or liabilities resulting from litigation; |
• | delays between our expenditures to develop and market new or enhanced solutions and the generation of revenue from those solutions; |
• | unforeseen liabilities or difficulties in integrating our acquisitions or newly acquired businesses; |
• | disruptions to our information technology systems; |
• | general economic and industry conditions that affect customer demand; |
• | the impact of the COVID-19 pandemic on our customers, suppliers, manufacturers, and operations; and |
• | changes in accounting rules and tax laws. |
• | the impact of the COVID-19 pandemic on our financial condition and the results of operations; |
• | our operating and financial performance and prospects; |
• | our quarterly or annual earnings or those of other companies in our industry compared to market expectations; |
• | conditions that impact demand for our services; |
• | future announcements concerning our business, our customers’ businesses, or our competitors’ businesses; |
• | the public’s reaction to our press releases, other public announcements, and filings with the SEC; |
• | the market’s reaction to our reduced disclosure and other requirements as a result of being an “emerging growth company” under the JOBS Act or a “smaller reporting company”; |
• | the size of our public float; |
• | coverage by or changes in financial estimates by securities analysts or failure to meet their expectations; |
• | market and industry perception of our success, or lack thereof, in pursuing our growth strategy; |
• | strategic actions by us or our competitors, such as acquisitions or restructurings; |
• | changes in laws or regulations which adversely affect the manufacturing industry generally or Shapeways specifically; |
• | changes in accounting standards, policies, guidance, interpretations, or principles; |
• | changes in senior management or key personnel; |
• | issuances, exchanges or sales, or expected issuances, exchanges, or sales of our capital stock; |
• | changes in our dividend policy; |
• | adverse resolution of new or pending litigation against us; and |
• | changes in general market, economic, and political conditions in the United States and global economies or financial markets, including those resulting from natural disasters, terrorist attacks, acts of war or other military conflicts, and responses to such events. |
• | a classified board of directors so that not all members of our Board of Directors are elected at one time; |
• | permit the Board of Directors to establish the number of directors and fill any vacancies and newly created directorships; |
• | provide that directors may only be removed for cause and only by a super majority vote; |
• | require super-majority voting to amend certain provisions of our charter and any provision of our bylaws; |
• | authorize the issuance of “blank check” preferred stock that our Board of Directors could use to implement a stockholder rights plan; |
• | eliminate the ability of our stockholders to call special meetings of stockholders; |
• | prohibit stockholder action by written consent, which requires all stockholder actions to be taken at a meeting of our stockholders; |
• | provide that the Board of Directors is expressly authorized to make, alter, or repeal our bylaws; and |
• | establish advance notice requirements for nominations for election to our Board of Directors or for proposing matters that can be acted upon by stockholders at annual stockholder meetings. |
• | Market conditions that may impact our pricing; |
• | Product mix changes between established manufacturing product offerings and new manufacturing product offerings; |
• | Mix changes between products we manufacture in house and through outsourced manufacturers; |
• | Our cost structure, including rent, materials costs, machine costs, labor rates, and other manufacturing operations costs; and |
• | Our level of investment in new technologies. |
Year Ended December 31, |
Change |
|||||||||||||||
(Dollars in thousands) |
2021 |
2020 |
$ |
% |
||||||||||||
Revenue |
$ | 33,623 | $ | 31,775 | $ | 1,848 | 6 | % |
Year Ended December 31, |
Change |
|||||||||||||||
(Dollars in thousands) |
2021 |
2020 |
$ |
% |
||||||||||||
Cost of Revenue |
$ | 17,673 | $ | 17,903 | $ | (230 | ) | (1 | )% |
Year Ended December 31, |
||||||||
(Dollars in thousands) |
2021 |
2020 |
||||||
Net income (loss) |
$ | 1,756 | $ | (3,168 | ) | |||
Debt forgiveness |
(2,000 | ) | — | |||||
Interest expense, net |
403 | 581 | ||||||
Depreciation and amortization |
593 | 473 | ||||||
Stock-based compensation |
2,907 | 721 | ||||||
Change in fair value of warrant liabilities |
(8,106 | ) | — | |||||
Income tax benefit |
(71 | ) | (29 | ) | ||||
Other |
15 | 30 | ||||||
|
|
|
|
|||||
Adjusted EBITDA |
$ | (4,503 | ) | $ | (1,392 | ) | ||
|
|
|
|
Year Ended December 31, |
||||||||
(Dollars in thousands) |
2021 |
2020 |
||||||
Net cash used in operating activities |
$ | (8,059 | ) | $ | (1,593 | ) | ||
Net cash used in investing activities |
(3,960 | ) | (104 | ) | ||||
Net cash provided by financing activities |
83,267 | 732 | ||||||
|
|
|
|
|||||
Net change in cash and cash equivalents and restricted cash |
$ | 71,248 | $ | (965 | ) | |||
|
|
|
|
• | pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company; |
• | provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and |
• | provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements. |
• | the Class I directors, Robert Jan Galema and Ryan Kearny, serving until the annual meeting to be held in 2022; |
• | the Class II directors, Alberto Recchi and Patrick S. Jones, serving until the annual meeting to be held in 2023; and |
• | the Class III directors, Josh Wolfe, Greg Kress and Leslie Campbell, serving until the annual meeting to be held in 2024. |
Name |
Age |
Position | ||
Greg Kress | 40 | Chief Executive Officer, Director | ||
Miko Levy | 43 | Chief Revenue Officer | ||
Jennifer Walsh | 47 | Chief Financial Officer | ||
Josh Wolfe | 44 | Chairman, Director | ||
Leslie Campbell | 63 | Director | ||
Robert Jan Galema | 55 | Director | ||
Patrick S. Jones | 77 | Director | ||
Ryan Kearny | 53 | Director | ||
Alberto Recchi | 48 | Director |
• | appointing, compensating, retaining, evaluating, terminating and overseeing the Company’s independent registered public accounting firm; |
• | discussing with the Company’s independent registered public accounting firm their independence from management; |
• | reviewing, with the Company’s independent registered public accounting firm, the scope and results of their audit; |
• | approving all audit and permissible non-audit services to be performed by the Company’s independent registered public accounting firm; |
• | overseeing the financial reporting process and discussing with management and the Company’s independent registered public accounting firm the quarterly and annual financial statements that the Company files with the SEC; |
• | overseeing the Company’s financial and accounting controls and compliance with legal and regulatory requirements; |
• | overseeing the Company’s policies on risk management, including reviewing the Company’s cybersecurity and other information technology risks, controls and procedures, including the Company’s plans to mitigate cybersecurity risks and to respond to data breaches; |
• | reviewing related person transactions; and |
• | establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal controls or auditing matters. |
Year |
Salary ($) (1) |
Bonus ($) |
Stock Awards ($) (3) |
Option Awards ($) (4) |
Non- Equity Incentive Compens- ation (5) |
All Other Compensat -ion ($) (6) |
Total ($) |
|||||||||||||||||||||||||
Gregory Kress |
2021 | $ | 359,021 | $ | 79,013 | $ | 1,046,949 | — | — | $ | 11,600 | $ | 1,496,583 | |||||||||||||||||||
Chief Executive Officer |
2020 | $ | 350,000 | $ | 200,000 | (2) |
— | $ | 242,959 | — | $ | 8,550 | $ | 801,509 | ||||||||||||||||||
Miko Levy |
2021 | $ | 262,885 | $ | 92,500 | $ | 51,490 | — | — | $ | 11,600 | $ | 418,475 | |||||||||||||||||||
Chief Revenue Officer |
2020 | $ | 250,000 | $ | 100,000 | — | $ | 24,296 | $ | 90,000 | $ | 8,550 | $ | 472,846 | ||||||||||||||||||
Jennifer Walsh |
2021 | $ | 333,375 | $ | 51,188 | $ | 840,983 | — | — | $ | 11,600 | $ | 1,237,146 | |||||||||||||||||||
Chief Financial Officer |
2020 | $ | 325,000 | $ | 97,500 | — | — | — | $ | 8,550 | $ | 431,050 |
(1) | The amounts in this column represent the base salaries earned in fiscal years 2021 and 2020. |
(2) | In 2020, Mr. Kress’s bonus was contingent upon closing funding for Legacy Shapeways. His original target was $150,000; however, the Legacy Shapeways board of directors approved a larger bonus of $200,000 in 2020 for superior performance as determined by the Legacy Shapeways board of directors, as shown above. |
(3) | There were no stock awards granted in 2020 to named executive officers. The amounts disclosed in this column for 2021 include the grant-date fair value for all stock awards, consisting of both time-based restricted stock units (“Transaction Bonus RSUs”) and performance-based restricted stock units (“Earn-Out RSUs”) computed in accordance with ASC Topic 718. The Transaction Bonus RSUs vested within 30 days of the Closing Date and settled in shares of Common Stock of the Company within 74 days following the Closing Date. The value of the Earn-Out RSUs are based on the probable outcome of the performance condition to which such awards are subject, which was calculated using a Monte Carlo valuation model in accordance with FASB ASC Topic 718. Based on the foregoing, the grant date fair value is $1.15 per share for the Earn-Out RSUs granted to each of Mr. Kress, Mr. Levy, and Ms. Walsh that are based on the relative price of the Company’s Common Stock. The grant date fair value of the Earn-Out RSUs, based upon the trading price of the Company’s Common Stock as of the grant date ($3.80), and assuming achievement at the maximum level of performance, is $308,949 for Mr. Kress, $51,490 for Mr. Levy, and $102,983 for Ms. Walsh. See Note 12 to Shapeways’ audited consolidated financial statements included elsewhere in this Report for a discussion of the assumptions made by Shapeways in determining the grant-date fair value of Shapeways’ equity awards. |
(4) | The amounts in this column represent the aggregate grant-date fair value of the granted option awards, computed in accordance with the FASB’s ASC Topic 718. See Note 12 to Shapeways’ audited consolidated financial statements included elsewhere in this Report for a discussion of the assumptions made by Shapeways in determining the grant-date fair value of Shapeways’ equity awards. |
(5) | The amount in this column represents commissions paid based on sales commission awards under Shapeways’ sales compensation incentive plan. |
(6) | The amounts in this column represent employer contributions made to each named executive officer’s 401(k) plan account in respect of 2021 and 2020. |
• | The threshold revenue growth target will be 60% of budgeted target growth, meaning that if revenue growth is below such threshold target, no bonus for such year will be payable; |
• | Between 60% and 100% achievement of the revenue growth target (i.e., between threshold and target achievement), the amount of the bonus for such year will be determined on a linear interpolation basis between 0% and 100% payment of target bonus; and |
• | Between 100% and 150% (or greater) achievement of the revenue growth target (i.e., between target and maximum achievement), the amount of the bonus for such year will be determined on a linear interpolation basis between 100% and 200% payout of target bonus. |
Number of Securities Underlying Unexercised Options (#) Vested |
Number of Securities Underlying Unexercised Options (#) Unvested |
Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) |
Option Exercise Price ($) |
Option Expiration Date |
Number of Shares or Units of Stock That Have Not Vested (#) |
Market Value of Shares or Units of Stock That Have Not Vested ($) |
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#) |
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($) |
||||||||||||||||||||||||||
Gregory Kress |
932,687 | (1) |
— | — | $ | 0.49 | (2) | 2/26/2028 | — | — | — | — | ||||||||||||||||||||||
Chief Executive Officer |
417,735 | (1) |
— | — | $ | 0.49 | 9/5/2028 | — | — | — | — | |||||||||||||||||||||||
1,007,444 | — | — | $ | 0.50 | 5/5/2030 | — | — | — | — | |||||||||||||||||||||||||
— | — | — | — | — | — | — | 268,651 | (2) |
$ | 996,695 | (2) | |||||||||||||||||||||||
Miko Levy |
302,233 | (1) |
— | — | $ | 0.50 | 10/29/2029 | — | — | — | — | |||||||||||||||||||||||
Chief Revenue Officer |
100,744 | — | — | $ | 0.50 | 5/5/2030 | — | — | — | — | ||||||||||||||||||||||||
— | — | — | — | — | — | — | 44,774 | (2) |
$ | 166,112 | (2) | |||||||||||||||||||||||
Jennifer Walsh |
250,980 | (1) |
— | — | $ | 0.49 | 9/5/2028 | — | — | — | — | |||||||||||||||||||||||
Chief Financial Officer |
89,497 | (1) |
— | — | $ | 0.49 | 9/5/2028 | — | — | — | — | |||||||||||||||||||||||
402,977 | — | — | $ | 0.50 | 7/23/2029 | — | — | — | — | |||||||||||||||||||||||||
— | — | — | — | — | — | — | 89,550 | (2) |
$ | 332,231 | (2) |
(1) | The option was immediately exercisable for all shares. As further described below, effective as of the closing of the Business Combination, the unvested shares underlying the options above were accelerated in full. |
(2) | Effective as of the closing of the Business Combination, the named executive officers received Earn-Out RSUs. Subject to the satisfaction of the share-price based performance vesting conditions, each Earn-out RSU represents the right to receive one share of Common Stock of the Company. The Earn-out RSUs will be subject to share-price based performance vesting conditions as follows: (i) if, at any time prior to September 29, 2024 (the “RSU Earn-out Period”), the Company’s Common Stock equals or exceeds $14.00 per share for 30 consecutive trading days, one half (1/2) of the Earn-out RSUs shall vest; and (ii) if, at any time prior to the completion of the RSU Earn-out Period, the Company’s Common Stock equals or exceeds $16.00 per share for 30 consecutive trading days, the remaining one half (1/2) of the Earn-out RSUs shall vest. If the RSU Performance Milestones (as defined below) are not met during the RSU Earn-out Period, then the applicable Earn-out RSUs shall be automatically forfeited. The fair value of the Earn-Out RSUs shown in the table assumes one half (1/2) of the Earn-out RSUs will vest and is based on the price of the Company’s Common Stock on the last trading day of 2021, which is $3.71 per share. |
Name |
Fees Earned or Paid in Cash ($) |
Stock Awards ($)(1) |
Total ($) |
|||||||||
Josh Wolfe |
$ | 17,750 | — | $ | 17,750 | |||||||
Leslie Campbell |
$ | 11,226 | $ | 215,000 | $ | 226,226 | ||||||
Robert Jan Galema |
$ | 12,750 | — | $ | 12,750 | |||||||
Patrick S. Jones |
$ | 14,750 | $ | 215,000 | $ | 229,750 | ||||||
Ryan Kearny |
$ | 11,250 | $ | 215,000 | $ | 226,250 | ||||||
Alberto Recchi |
$ | 14,750 | — | $ | 14,750 |
(1) | The amounts in this column represent the aggregate grant-date fair value of the granted RSU awards, computed in accordance with the FASB’s ASC Topic 718. See Note 12 to Shapeways’ audited consolidated financial statements included elsewhere in this Report for a discussion of the assumptions made by Shapeways in determining the grant-date fair value of Shapeways’ equity awards. Subject to the director’s continuing service, the service-based requirement will be satisfied in equal annual installments over a 3-year period, and the vesting date in each year will be the anniversary of the date of grant (or if there is no corresponding date, the last date of the month). Upon a transaction constituting a “Change in Control” as defined in the Incentive Plan, the service-based requirement applicable to outstanding equity awards granted pursuant thereto shall be deemed satisfied in full upon the effective date of such transaction. |
• | Each non-employee director receives an annual cash retainer of $35,000. |
• | A non-executive chairperson is paid an additional annual cash retainer of $30,000. |
• | To the extent Shapeways appoints a director as “lead independent director” (if not the chairperson), such director is paid an additional annual cash retainer of $17,500. |
• | Directors receive an additional annual cash retainer, as set forth below, for their service on Board committees as follows: |
Committee |
Chairperson |
Member |
||||||
Audit |
$ | 20,000 | $ | 10,000 | ||||
Compensation and Human Capital Committee |
$ | 12,000 | $ | 6,000 | ||||
Nominating and Governance |
$ | 8,000 | $ | 4,000 |
• | All cash retainers are paid in arrears in quarterly installments within 30 days after the fiscal quarter end. |
• | each person known by Shapeways to be the beneficial owner of more than 5% of outstanding common stock on such date; |
• | each current executive officer of Shapeways and each member of Shapeways’ board of directors; and |
• | all of Shapeways’ executive officers and directors as a group. |
Name and Address of Beneficial Owner (1) |
Number of Shares Beneficially Owned |
Percentage of Outstanding Shares |
||||||
Directors and Named Executive Officers |
||||||||
Josh Wolfe (2) |
7,134,051 | 14.6 | % | |||||
Greg Kress (3) |
2,475,871 | 4.8 | % | |||||
Jennifer Walsh (4) |
870,171 | 1.8 | % | |||||
Miko Levy (5) |
402,977 | * | ||||||
Alberto Recchi (6) |
951,531 | 1.9 | % | |||||
Patrick Jones |
13,000 | * | ||||||
Robert Jan Galema (7) |
3,508,963 | 7.2 | % | |||||
Ryan Kearny |
— | — | ||||||
Leslie Campbell |
— | — | ||||||
All executive officers and directors as a group (9 individuals) |
15,356,564 | 29.4 | % | |||||
5% Beneficial Holders |
||||||||
Andreessen Horowitz Fund III, L.P. (8) |
5,304,463 | 10.9 | % | |||||
Index Ventures (9) |
5,418,459 | 11.1 | % | |||||
Koninklijke Philips N.V. (F/K/A Koninklijke Philips Electronics) (10) |
4,146,478 | 8.5 | % | |||||
Lux Capital (11) |
7,134,051 | 14.6 | % | |||||
Stichting Depositary INKEF Investment Fund (12) |
3,508,963 | 7.2 | % | |||||
Union Square Ventures 2008, L.P. (13) |
6,107,670 | 12.5 | % |
* | Less than 1% |
(1) | Unless otherwise indicated, the business address of each executive officer and director of the Company is c/o Shapeways Holdings, Inc., 30-02 48th Avenue, Long Island City, NY 11101. |
(2) | Consists of (i) 3,811,111 shares held by Lux Ventures III, L.P., of which 381,111 shares are subject to the Earnout Terms (as defined in Note 3 to the consolidated financial statements included in this Report), (ii) 3,148,460 shares held by Lux Co-Invest Opportunities, L.P., of which 284,846 shares are subject to the Earnout Terms, (iii) 172,666 shares held by Lux Ventures Cayman III, L.P., of which 17,266 shares are subject to the Earnout Terms and (iv) 1,814 shares held by Lux Ventures III Special Founders Fund, L.P., of which 181 shares are subject to the Earnout Terms. Lux Co-Invest Partners, LLC is the general partner of Lux Co-Invest Opportunities, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Co-Invest Opportunities, L.P. Lux Venture Partners III, LLC is the general partner of Lux Ventures III, LP and of Lux Ventures III Special Founders Fund, L.P. Lux Ventures Cayman III General Partner Limited is the general partner of Lux Ventures Cayman III, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures Cayman III, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited. The individual managers, as the sole managers of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures III, L.P., Lux Co-Invest Opportunities, L.P., Lux Ventures Cayman III, L.P. and Lux Ventures III Special Founders Fund, L.P. Each of Lux Venture Partners III, LLC, Lux Co-Invest Partners, LLC and Lux Ventures Cayman III General Partner Limited, and the individual managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein. The address for these entities and individuals is c/o Lux Capital Management, 920 Broadway, 11th Floor, New York, NY 10010. |
(3) | Includes 2,357,866 shares subject to options, all of which are fully vested and exercisable. |
(4) | Includes 743,454 shares subject to options, all of which are fully vested and exercisable. |
(5) | Includes 402,977 shares subject to options, all of which are fully vested and exercisable. |
(6) | Consists of (i) 653,123 shares and (ii) 298,408 warrants exercisable for shares of common stock held by Alberto Recchi through an entity he controls, Ampla Capital LLC. The address for Ampla Capital LLC is 1049 Park Ave. 14A, New York, NY 10028. |
(7) | Consists of 3,508,963 shares held by Stichting Depositary INKEF Investment Fund, of which 325,896 shares are subject to the Earnout Terms. Robert John Galema, Roel Bulthuis, Corne Jansen and Wolfgang Noldeke together exercise voting and investment control over shares held by Stichting Depositary INKEF Investment Fund. The address for these entities and individuals is Gustav Mahlerplein 66b, 9th Floor, 1082 MA, Amsterdam, the Netherlands. |
(8) | Consists of (i) 4,989,040 shares received by Andreessen Horowitz Fund III, L.P. for itself and as nominee for Andreessen Horowitz Fund III-A, L.P., Andreessen Horowitz Fund III-B, L.P. and Andreessen Horowitz Fund III-Q, L.P. (collectively the “AH Fund III Entities”), in the Business Combination as an equityholder of Legacy Shapeways, of which 488,904 shares are subject to the Earnout Terms and (ii) 315,423 shares held by AH Parallel Fund III, L.P., of which 31,542 shares are subject to the Earnout Terms, for itself and as a nominee for AH Parallel Fund III-A, L.P., AH Parallel Fund III-B, L.P. and AH Parallel Fund III-Q, L.P. The address for the entities set forth herein is 2865 Sand Hill Road, Suite 101, Menlo Park, CA 94025. |
(9) | Consists of (i) 5,307,738 shares held by Index Ventures V (Jersey), L.P. (“Ventures”), of which 530,773 shares are subject to the Earnout Terms, (ii) 42,994 shares held by Index Ventures V Parallel Entrepreneur Fund (Jersey), L.P. (“Entrepreneur”), of which 4,299 shares are subject to the Earnout Terms and (iii) 67,728 shares held by Yucca (Jersey) SLP (“Yucca” and, together with Ventures and Entrepreneur, the “Index Funds”), of which 6,773 shares are subject to the Earnout Terms. The principal place of business of the Index Funds is 44 Esplanade, St. Helier, Jersey JE4 9WG, Channel Islands. |
(10) | Includes 414,647 shares subject to the Earnout Terms. The address for Koninklijke Philips N.V. (F/K/A Koninklijke Philips Electronics N.V.) is Philips International BV, Amstelplein 2, 1096 BC Amsterdam, the Netherlands. |
(11) | Includes the shares referenced in footnote (2). |
(12) | Includes the shares referenced in footnote (7). |
(13) | Consists of 6,107,670 shares held by Union Square Ventures 2008, L.P., of which 580,767 shares are subject to the Earnout Terms. The address for Union Square Ventures 2008, L.P. is 2865 Sand Hill Road, Suite 101, Menlo Park, CA 94025. |
Equity compensation plans |
Number of securities to be issued upon exercise of outstanding options, warrants and rights |
Weighted-average exercise price of outstanding options, warrants and rights |
Number of securities remaining available for future issuance under equity compensation plans |
|||||||||
Equity compensation plans approved by security holders |
5,466,835 | (1) |
$ | 0.63 | (2) |
7,446,310 | (3) | |||||
Equity compensation plans not approved by security holders |
— | — | — | |||||||||
Total |
5,466,835 | (1) |
$ | 0.63 | (2) |
7,446,310 | (3) |
(1) | Represents 4,806,387 outstanding options under the 2010 Stock Plan and 660,448 restricted stock units under the 2021 Equity Incentive Plan. |
(2) | Represents the weighted-average exercise price of the 4,806,387 outstanding options. |
(3) | Includes 6,550,589 and 895,721 shares available for future issuance under the 2021 Equity Incentive Plan and 2021 Employee Stock Purchase Plan, respectively. |
• | Shapeways has been or is to be a participant; |
• | the amount involved exceeded or exceeds the lesser of (a) $120,000 or (b) one percent of the average of Shapeways’ total assets at year-end for the fiscal years ended December 31, 2021 and 2020; and |
• | any of Shapeways’ directors, executive officers or holders of more than 5% of its capital stock prior to the Business Combination, or any immediate family member of, or person sharing the household with, any of these individuals, had or will have a direct or indirect material interest. |
Legacy Shapeways Stockholder |
Principal Balance of Convertible Promissory Notes |
Converted Series E Preferred Shares |
||||||
Union Square Ventures 2008, L.P. |
$ | 1,666,667 | 565,425 | |||||
Lux Co-Invest Opportunities, L.P. |
$ | 1,666,667 | 565,425 | |||||
Stichting Depositary INKEF Investment Fund |
$ | 1,666,667 | 565,425 |
• | any person who is, or at any time during the applicable period was, one of the Company’s executive officers or one of the Company’s directors; |
• | any person who is known by the Company to be the beneficial owner of more than 5% of the Company’s voting shares; |
• | any immediate family member of any of the foregoing persons, which means any child, stepchild, parent, stepparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, in-law or sister-in-law |
• | any firm, corporation or other entity in which any of the foregoing persons is a partner or principal, or in a similar position, or in which such person has a 10% or greater beneficial ownership interest. |
For the Fiscal Year Ended December 31, |
||||||||
2021 |
2020 (5) |
|||||||
Audit Fees (1) |
$ | 255,518 | $ | 93,503 | ||||
Audit-Related Fees (2) |
159,269 | 64,991 | ||||||
Tax Fees (3) |
46,610 | 28,428 | ||||||
All Other Fees (4) |
92,560 | — | ||||||
Total |
$ | 553,957 | $ | 186,922 | ||||
1. | Audit Fees 10-Q or services that are normally provided by our independent registered public accounting firm in connection with statutory and regulatory filings or engagements. |
2. | Audit-Related Fees |
3. | Tax Fees |
4. | All Other Fees |
5. | Fees presented for the year fiscal year ended December 31, 2020 pertain to Legacy Shapeways. |
a. | The following documents are filed as part of this Report: |
i. | Financial Statements (see pages F-1 through F-34 of this Report): |
1. | Report of Independent Registered Public Accounting Firm |
2. | Balance Sheets |
3. | Statements of Operations and Comprehensive Loss |
4. | Statements of Preferred and Common Stock and Stockholder’s Equity (Deficit) |
5. | Statements of Cash Flows |
6. | Notes to Financial Statements |
ii. | Financial Statement Schedules: |
1. | All financial statement schedules are omitted because the information is inapplicable or presented in the notes to the financial statements |
b. | The exhibits listed in the accompanying index to exhibits are filed or incorporated by reference as part of this Report. |
* | Filed herewith. |
** | Furnished herewith. |
+ | The schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request. |
# | Indicates a management or compensatory plan. |
Shapeways Holdings, Inc. | ||||||
Dated: March 31, 2022 | By: | /s/ Jennifer Walsh | ||||
Jennifer Walsh | ||||||
Chief Financial Officer | ||||||
(Principal Financial and Accounting Officer) |
Name |
Title |
Date | ||
/s/ Greg Kress |
Chief Executive Officer and Director | March 31, 2022 | ||
Greg Kress | ( Principal Executive Officer |
|||
/s/ Jennifer Walsh |
Chief Financial Officer | March 31, 2022 | ||
Jennifer Walsh | ( Principal Financial and Accounting Officer |
|||
/s/ Josh Wolfe |
Executive Chairman and Director | March 31, 2022 | ||
Josh Wolfe | ||||
/s/ Leslie Campbell |
Director | March 31, 2022 | ||
Leslie Campbell | ||||
/s/ Robert Jan Galema |
Director | March 31, 2022 | ||
Robert Jan Galema | ||||
/s/ Patrick S. Jones |
Director | March 31, 2022 | ||
Patrick S. Jones | ||||
/s/ Ryan Kearny |
Director | March 31, 2022 | ||
Ryan Kearny | ||||
/s/ Alberto Recchi |
Director | March 31, 2022 | ||
Alberto Recchi |
Item 8. |
Financial Statements and Supplementary Data. |
Page | ||
F-2 | ||
F-3 | ||
F-4 | ||
F-5 | ||
F-6 | ||
F-7 |
December 31, |
||||||||
2021 |
2020 |
|||||||
Assets |
||||||||
Current assets |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Restricted cash |
||||||||
Accounts receivable |
||||||||
Inventory |
||||||||
Promissory note due from related party |
||||||||
Prepaid expenses and other current assets |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
Property and equipment, net |
||||||||
Right-of-use |
||||||||
Goodwill |
||||||||
Security deposits |
||||||||
|
|
|
|
|||||
Total assets |
$ | $ | ||||||
|
|
|
|
|||||
Liabilities and Stockholders’ Equity (Deficit) |
||||||||
Current liabilities |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued expenses and other liabilities |
||||||||
Current portion of long-term debt |
||||||||
Operating lease liabilities, current |
||||||||
Deferred revenue |
||||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
Operating lease liabilities, net of current portion |
||||||||
Warrant liabilities |
||||||||
Long-term debt |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
|
|
|
|
|||||
Commitments and contingencies |
||||||||
Stockholders’ equity (deficit) (1) |
||||||||
Preferred stock ($ |
||||||||
Common stock ($ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Accumulated other comprehensive loss |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total stockholders’ equity (deficit) |
( |
) | ||||||
|
|
|
|
|||||
Total liabilities and stockholders’ equity (deficit) |
$ | $ | ||||||
|
|
|
|
(1) | Retroactively restated for the reverse recapitalization as described in Notes 1 and 3. |
Year Ended December 31, |
||||||||
2021 |
2020 |
|||||||
Revenue, net |
$ | $ | ||||||
Cost of revenue |
||||||||
|
|
|
|
|||||
Gross profit |
||||||||
Operating expenses |
||||||||
Selling, general and administrative |
||||||||
Research and development |
||||||||
Amortization and depreciation |
||||||||
|
|
|
|
|||||
Total operating expenses |
||||||||
|
|
|
|
|||||
Loss from operations |
( |
) | ( |
) | ||||
Other income (expense) |
||||||||
Long-term debt forgiveness |
||||||||
Change in fair value of warrant liabilities |
||||||||
Interest expense |
( |
) | ( |
) | ||||
Interest income |
||||||||
Other income |
||||||||
Loss on disposal of assets |
( |
) | ||||||
|
|
|
|
|||||
Total other income (expense), net |
( |
) | ||||||
|
|
|
|
|||||
Income (loss) before income tax benefit |
( |
) | ||||||
Income tax benefit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net income (loss) |
( |
) | ||||||
Deemed dividend—Earnout Shares |
( |
) | ||||||
|
|
|
|
|||||
Net loss attributable to common stockholders |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
|||||
Net income (loss) per share: |
||||||||
Basic |
$ | $ | ( |
) | ||||
|
|
|
|
|||||
Diluted |
$ | $ | ( |
) | ||||
|
|
|
|
|||||
Net loss per share attributable to common stockholders: |
||||||||
Basic |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
|||||
Diluted |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
|||||
Weighted average common shares outstanding: (1) |
||||||||
Basic |
||||||||
|
|
|
|
|||||
Diluted |
||||||||
|
|
|
|
|||||
Other comprehensive (loss) income |
||||||||
Foreign currency translation adjustment |
( |
) | ||||||
|
|
|
|
|||||
Comprehensive loss |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
(1) | Retroactively restated for the reverse recapitalization as described in Notes 1 and 3. |
Preferred Stock |
Common Stock |
Additional Paid-In |
Accumulated |
Accumulated Other Comprehensive |
Total Stockholders’ |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Loss |
Equity (Deficit) |
|||||||||||||||||||||||||
Balance at January 1, 2020 (as previously reported) |
$ | $ | $ | $ | ( |
) | $ | ( |
) | $ | ||||||||||||||||||||||
Retroactive application of reverse recapitalization |
( |
) | ( |
) | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance at January 1, 2020 (after effect of reverse recapitalization) |
( |
) | ( |
) | ||||||||||||||||||||||||||||
Issuance of Legacy Shapeways common stock upon exercise of stock options |
||||||||||||||||||||||||||||||||
Stock-based compensation expense |
— | — | ||||||||||||||||||||||||||||||
Net loss |
— | — | ( |
) | ( |
) | ||||||||||||||||||||||||||
Foreign currency translation |
— | — | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance at December 31, 2020 |
— |
— |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||
Issuance of Legacy Shapeways common stock upon exercise of stock options |
— | — | — | — | — | |||||||||||||||||||||||||||
Issuance of Legacy Shapeways convertible Series B-1 preferred stock resulting from exercise of warrants |
— | — | — | — | — | |||||||||||||||||||||||||||
Issuance of Legacy Shapeways common stock upon conversion of convertible notes |
— | — | — | — | — | |||||||||||||||||||||||||||
Issuance of Legacy Shapeways common stock upon exercise of warrants |
— | — | — | — | — | — | — | |||||||||||||||||||||||||
Issuance of Legacy Shapeways convertible Series D preferred stock upon exercise of warrants |
— | — | — | — | — | — | — | |||||||||||||||||||||||||
Repurchase of Legacy Shapeways common stock |
— | — | ( |
) | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||
Effect of Merger and recapitalization, net of redemptions and issuance costs |
— | — | — | — | ||||||||||||||||||||||||||||
Issuance of common stock pursuant to PIPE financing, net of issuance costs |
— | — | — | — | ||||||||||||||||||||||||||||
Issuance of common stock upon exercise of stock options |
— | — | — | — | — | |||||||||||||||||||||||||||
Issuance of common stock for settlement of restricted stock units |
— | — | — | — | — | |||||||||||||||||||||||||||
Tax payments related to shares withheld for vested restricted stock units |
— | — | ( |
) | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||
Stock-based compensation expense |
— | — | — | — | — | — | ||||||||||||||||||||||||||
Transfer of Private Warrants to Public Warrants |
— | — | — | — | — | — | ||||||||||||||||||||||||||
Net income |
— | — | — | — | — | — | ||||||||||||||||||||||||||
Foreign currency translation |
— | — | — | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance at December 31, 2021 |
$ | $ | $ | ( |
) | $ | ( |
) | $ | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Retroactively restated for the reverse recapitalization as described in Notes 1 and 3. |
Year Ended December 31, |
||||||||
2021 |
2020 |
|||||||
Cash flows from operating activities: |
||||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
Depreciation and amortization |
||||||||
Loss on disposal of assets |
||||||||
Stock-based compensation expense |
||||||||
Non-cash lease expense |
||||||||
Non-cash debt forgiveness |
( |
) | ||||||
Change in fair value of warrant liabilities |
( |
) | ||||||
Change in operating assets and liabilities: |
||||||||
Accounts receivable |
( |
) | ( |
) | ||||
Inventory |
( |
) | ( |
) | ||||
Prepaid expenses and other assets |
( |
) | ( |
) | ||||
Interest on promissory note due from related party |
||||||||
Security deposits |
||||||||
Accounts payable |
( |
) | ||||||
Accrued expenses and other liabilities |
||||||||
Lease liabilities |
( |
) | ( |
) | ||||
Deferred revenue |
||||||||
Deferred rent |
( |
) | ||||||
|
|
|
|
|||||
Net cash used in operating activities |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Cash flows from investing activities: |
||||||||
Purchases of property and equipment |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net cash used in investing activities |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Cash flows from financing activities: |
||||||||
Principal payments on capital leases |
( |
) | ||||||
Proceeds from issuance of common stock |
||||||||
Proceeds received from exercise of preferred stock warrants |
||||||||
Tax payments related to shares withheld for vested restricted stock units |
( |
) | ||||||
Effect of Merger, net of transaction costs |
||||||||
Repayments of loans payable |
( |
) | ( |
) | ||||
Proceeds from loans payable |
||||||||
|
|
|
|
|||||
Net cash provided by financing activities |
||||||||
|
|
|
|
|||||
Net change in cash and cash equivalents and restricted cash |
$ | $ | ( |
) | ||||
|
|
|
|
|||||
Effect of change in foreign currency exchange rates on cash and cash equivalents and restricted cash |
( |
) | ||||||
Cash and cash equivalents and restricted cash at beginning of year |
|
|||||||
|
|
|
|
|||||
Cash and cash equivalents and restricted cash at end of year |
$ | |
$ | |||||
|
|
|
|
|||||
Supplemental disclosure of cash and non-cash transactions: |
||||||||
Cash paid for interest |
$ | $ | ||||||
|
|
|
|
|||||
Issuance of Legacy Shapeways common stock upon conversion of convertible notes |
$ | $ | ||||||
|
|
|
|
|||||
Repurchase of Legacy Shapeways common stock |
$ | ( |
) | $ | ||||
|
|
|
|
• | Legacy Shapeways’ directors represented the majority of the new board of directors of the Company; |
• | The executive officers and senior management of Legacy Shapeways are the executive officers and senior management of the Company; |
• | The assets of Legacy Shapeways represent a significant majority of the assets of the Company (excluding cash formerly held in the Galileo trust account); and |
• | The business of the Company is the continued business of Legacy Shapeways. The business of the Company will continue to focus on Legacy Shapeways’ core offerings related to the facilitation of the sale, design and manufacturing of 3D printed items. |
December 31, |
||||||||
2021 |
2020 |
|||||||
Cash and cash equivalents |
$ | $ | ||||||
Restricted cash |
||||||||
|
|
|
|
|||||
$ | $ | |||||||
|
|
|
|
Asset Category |
Depreciable Life | |
Machinery and equipment |
||
Computers and IT equipment |
||
Furniture and fixtures |
||
Leasehold improvements |
* |
** | Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or estimated useful life of the asset. |
Year Ended December 31, |
||||||||
2021 |
2020 |
|||||||
Common stock warrants |
||||||||
Earnout Shares |
||||||||
Unvested RSUs |
Recapitalization |
||||
Cash—Galileo trust and cash, net of redemption |
$ | |||
Cash—PIPE Investment, net of transaction costs |
||||
Less: transaction costs and advisory fees allocated to equity |
( |
) | ||
|
|
|||
Effect of Merger, net of redemption, transaction costs and advisory costs |
$ | |||
|
|
Recapitalization |
||||
Cash—Galileo trust and cash, net of redemption |
$ | |||
Non-cash net working capital assumed from Galileo |
||||
Less: fair value of Private and Sponsor Warrant liabilities |
( |
) | ||
Less: transaction costs and advisory fees allocated to equity |
( |
) | ||
|
|
|||
Effect of Merger, net of redemption, transaction costs and advisory costs |
$ | |||
|
|
Number of Shares |
||||
Common stock, outstanding prior to Business Combination |
||||
Less: redemption of Galileo shares |
( |
) | ||
|
|
|||
Common stock of Galileo |
||||
Galileo founder and representative shares, net of forfeited shares |
||||
Shares issued in PIPE Investment |
||||
|
|
|||
Merger and PIPE Investment—common stock |
||||
Legacy Shapeways shares—common stock (1) |
||||
|
|
|||
Total shares of common stock immediately after Business Combination |
||||
|
|
(1) | Includes |
Year Ended December 31, |
||||||||
2021 |
2020 |
|||||||
Major products/service lines: |
||||||||
Direct sales |
$ | $ | ||||||
Marketplace sales |
||||||||
Software |
||||||||
|
|
|
|
|||||
Total revenue |
$ | $ | ||||||
|
|
|
|
|||||
Timing of revenue recognition: |
||||||||
Products transferred at a point in time |
$ | $ | ||||||
Products and services transferred over time |
||||||||
|
|
|
|
|||||
Total revenue |
$ | $ | ||||||
|
|
|
|
Year Ended December 31, |
||||||||
2021 |
2020 |
|||||||
Balance at beginning of year |
$ | $ | ||||||
Deferred revenue recognized during period |
( |
) | ( |
) | ||||
Additions to deferred revenue during period |
||||||||
|
|
|
|
|||||
Balance at end of year |
$ | $ | ||||||
|
|
|
|
December 31, |
||||||||
2021 |
2020 |
|||||||
Raw materials |
$ | $ | ||||||
Work-in-process |
||||||||
Finished goods |
||||||||
|
|
|
|
|||||
Total |
$ | $ | ||||||
|
|
|
|
December 31, |
||||||||
2021 |
2020 |
|||||||
Prepaid expenses |
$ | $ | ||||||
Prepaid insurance |
||||||||
Security deposits |
||||||||
VAT receivable |
||||||||
Other current assets |
||||||||
|
|
|
|
|||||
Total |
$ | $ | ||||||
|
|
|
|
December 31, |
||||||||
2021 |
2020 |
|||||||
Machinery and equipment |
$ | $ | ||||||
Computers and IT equipment |
||||||||
Furniture and fixtures |
||||||||
Leasehold improvements |
||||||||
Less: Accumulated depreciation |
( |
) | ( |
) | ||||
Property and equipment, net |
$ | $ | ||||||
December 31, |
||||||||
2021 |
2020 |
|||||||
Accrued selling expenses |
$ | $ | ||||||
Accrued compensation |
||||||||
Interest payable |
||||||||
Taxes payable |
||||||||
Shapeways credits |
||||||||
Other |
||||||||
Total |
$ | $ | ||||||
Year Ended December 31, |
||||||||
2021 |
2020 |
|||||||
Operating lease expense |
$ | $ | ||||||
Finance lease expense |
— | |||||||
Interest expense on finance lease liabilities |
— | |||||||
Short-term lease expense |
— | |||||||
Total lease cost |
$ | $ | ||||||
December 31, |
||||||||
2021 |
2020 |
|||||||
Assets: |
||||||||
Right-of-use |
$ | $ | ||||||
Total lease assets |
$ | $ | ||||||
Liabilities: |
||||||||
Current liabilities: |
||||||||
Operating lease liabilities, current |
$ | $ | ||||||
Non-current liabilities: |
||||||||
Operating lease liabilities, net of current portion |
$ | |||||||
Total lease liability |
$ | $ | ||||||
Year Ended December 31, |
||||||||
2021 |
2020 |
|||||||
Operating cash flows from operating leases |
$ | $ | ||||||
Operating cash flows from finance leases |
— | |||||||
Financing cash flows from finance leases |
— | |||||||
Lease liabilities arising from obtaining right-of-use |
— |
2022 |
$ | |||
2023 |
||||
2024 |
||||
2025 |
||||
|
|
|||
Total minimum lease payments |
||||
Less effects of discounting |
( |
) | ||
|
|
|||
Present value of future minimum lease payments |
$ | |||
|
|
December 31, |
||||||||
2021 |
2020 |
|||||||
Dutch Landlord Loan |
$ | $ | ||||||
Term Loan |
||||||||
Convertible Promissory Notes |
||||||||
PPP Loan |
||||||||
|
|
|
|
|||||
Less: current portion |
( |
) | ||||||
|
|
|
|
|||||
Long-term debt |
$ | $ | ||||||
|
|
|
|
Weighted average grant date fair value |
$ |
|||
Expected term (in years) |
||||
Expected volatility |
% | |||
Risk-free interest rate |
% | |||
Dividend yield |
Year Ended December 31, |
||||||||
2021 |
2020 |
|||||||
Strike price |
$ | $ | ||||||
Expected term (in years) |
||||||||
Expected volatility |
% | % | ||||||
Risk-free interest rate |
% | % | ||||||
Dividend yield |
Shares Underlying Options |
Weighted Average Exercise Price |
Weighted Average Remaining Contractual Term (in years) |
Aggregate Intrinsic Value (in thousands) |
|||||||||||||
Outstanding at January 1, 2021 (as previously reported) |
$ | $ | — | |||||||||||||
Retroactive application of reverse recapitalization |
( |
) | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Outstanding as of January 1, 2021, effect of Merger |
$ | $ | — | |||||||||||||
Granted |
— | |||||||||||||||
Forfeited |
( |
) | — | — | ||||||||||||
Exercised |
( |
) | — | $ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Outstanding at December 31, 2021 |
$ | $ | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Exercisable at December 31, 2021 |
$ | $ | ||||||||||||||
|
|
|
|
|
|
|
|
Restricted Stock Units |
Weighted Average Grant Date Fair Value per Share |
|||||||
Outstanding at January 1, 2021 |
$ | |||||||
Granted |
||||||||
Forfeited |
( |
) | ||||||
Vested |
( |
) | ||||||
|
|
|
|
|||||
Outstanding at December 31, 2021 |
$ | |||||||
|
|
|
|
|||||
Exercisable at December 31, 2021 |
$ | |||||||
|
|
|
|
Description |
Level |
December 31, 2021 |
December 31, 2020 |
|||||||||
Liabilities: |
||||||||||||
Warrant liabilities |
3 | $ | $ |
December 31, 2021 |
At Closing (September 29, 2021) |
|||||||
Stock price on valuation date |
$ | $ | ||||||
Exercise price per share |
$ | $ | ||||||
Expected life |
||||||||
Volatility |
% | % | ||||||
Risk-free rate |
% | % | ||||||
Dividend yield |
% | % | ||||||
|
|
|
|
|||||
Fair value per warrant |
$ | $ | ||||||
|
|
|
|
Warrant Liabilities |
||||
Balance at December 31, 2020 |
$ | — | ||
Additions pursuant to Merger |
||||
Transfer of Private Warrants to Public Warrants |
( |
) | ||
Change in fair value |
( |
) | ||
|
|
|||
Balance at December 31, 2021 |
$ | |||
|
|
Year Ended December 31, |
||||||||
2021 |
2020 |
|||||||
Income tax provision: |
||||||||
Non-US |
$ | ( |
) | $ | ( |
) | ||
Federal |
||||||||
State |
||||||||
|
|
|
|
|||||
Provision for income taxes |
$ | ( |
) | $ | ( |
) | ||
|
|
|
|
Year Ended December 31, |
||||||||
2021 |
2020 |
|||||||
Federal statutory income tax rate |
% | % | ||||||
State and local income taxes, net of federal benefit |
( |
)% | % | |||||
Nondeductible expenses |
% | ( |
)% | |||||
Loan forgiveness |
( |
)% | % | |||||
Warrant liabilities |
( |
)% | % | |||||
Stock-based compensation |
( |
)% | ( |
)% | ||||
Change in state tax rates |
% | ( |
)% | |||||
Change in valuation allowance |
% | ( |
)% | |||||
True-up adjustments |
( |
)% | % | |||||
Foreign rate differential |
% | ( |
)% | |||||
|
|
|
|
|||||
( |
)% | % | ||||||
|
|
|
|
Year Ended December 31, |
||||||||
2021 |
2020 |
|||||||
Deferred tax assets: |
||||||||
Accrued expense |
$ | $ | ||||||
Sec. 263(a) |
||||||||
Stock-based compensation |
||||||||
ASC 842—Right of use lease liability |
||||||||
Fixed assets |
||||||||
Net operating losses |
||||||||
Tax credits |
||||||||
Other |
||||||||
Less: valuation allowance |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total deferred tax assets |
$ | $ | ||||||
|
|
|
|